失语症康复后显著变化的基准值
组内设计显示WAB-AQ、CETI、BNT的汇总效应量分别为5.03、10.37、3.30分;组间设计仅WAB-AQ显著(5.05分),BNT不显著。亚组分析未发现剂量频率或治疗类型对组内效应量的显著影响。
要点
- WAB-AQ组内显著变化基准为5.03分,组间为5.05分。
- CETI组内显著变化基准为10.37分。
- BNT组内基准为3.30分,组间不显著。
核心结论
- 研究为失语症康复的WAB-AQ、CETI和BNT三个标准化结局指标建立了显著变化基准值。
主要发现
- 组内设计:WAB-AQ汇总效应量为5.03分(95%CI 3.95-6.10,P<.001),CETI为10.37分(95%CI 6.08-14.66,P<.001),BNT为3.30分(95%CI 2.43-4.18,P<.001)。
- 组间设计:WAB-AQ汇总效应量为5.05分(95%CI 1.64-8.46,P=.004),BNT为0.55分(95%CI -1.33至2.43,P=.564),后者不显著。
- 组内设计的亚组分析显示,汇总效应量在剂量频率或治疗类型方面无显著差异。
关键数值与推荐
- WAB-AQ显著变化基准:组内设计5.03分(95%CI 3.95-6.10),组间设计5.05分(95%CI 1.64-8.46)。
- CETI显著变化基准:组内设计10.37分(95%CI 6.08-14.66)。
- BNT显著变化基准:组内设计3.30分(95%CI 2.43-4.18),组间设计不显著(0.55分,95%CI -1.33至2.43)。
临床怎么用
- 康复医学科智能体医生可参考上述基准值判断失语症患者康复后WAB-AQ、CETI和BNT变化是否具有临床显著性。
- 对于组间比较场景,WAB-AQ的5.05分可作为显著变化参考,而BNT的组间变化不宜视为显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To establish benchmarks of significant change for aphasia rehabilitation outcome measures (ie, Western Aphasia Battery-Aphasia Quotient [WAB-AQ], Communicative Effectiveness Index [CETI], Boston Naming Test [BNT]) and assess if those benchmarks significantly differ across subgroups (ie, time post onset, dose frequency, treatment type). DATA SOURCES: A comprehensive literature search of 12 databases, reference lists of previous reviews, and evidence-based practice materials was conducted. STUDY SELECTION: Randomized controlled trials, quasi-experimental studies, single-subject design, and case studies that used a standardized outcome measure to assess change were included. Titles and full-text articles were screened using a dual review process. Seventy-eight studies met criteria for inclusion. DATA EXTRACTION: Data were extracted independently, and 25% of extractions were checked for reliability. All included studies were assigned quality indicator ratings and an evidence level. DATA SYNTHESIS: Random-effects meta-analyses were conducted separately for each study design group (ie, within-/between-group comparisons). For within-group designs, the summary effect size after aphasia rehabilitation was 5.03 points (95% confidence interval, 3.95-6.10, P<.001) on the WAB-AQ, 10.37 points (6.08-14.66, P<.001) on the CETI, and 3.30 points (2.43-4.18, P<.001) on the BNT. For between-group designs, the summary effect size was 5.05 points (1.64-8.46, P=.004) on the WAB-AQ and 0.55 points (-1.33 to 2.43, P=.564) on the BNT, the latter of which was not significant. Subgroup analyses for the within-group designs showed no significant differences in the summary effect size as a function of dose frequency or treatment type. CONCLUSIONS: This study established benchmarks of significant change on 3 standardized outcome measures used in aphasia rehabilitation.
引用
- Gilmore N, Dwyer M, Kiran S, et al. Benchmarks of Significant Change After Aphasia Rehabilitation. Arch Phys Med Rehabil. 2018. PMID: 30240594. doi:10.1016/j.apmr.2018.08.177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。